|
MFSD11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.214400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.737700E-02 |
| Normal-vs-Stage2 |
1.696610E-01 |
| Normal-vs-Stage3 |
8.259600E-01 |
| Normal-vs-Stage4 |
6.643200E-01 |
| Stage1-vs-Stage2 |
9.402400E-01 |
| Stage1-vs-Stage3 |
2.984400E-01 |
| Stage1-vs-Stage4 |
7.632000E-01 |
| Stage2-vs-Stage3 |
4.152200E-01 |
| Stage2-vs-Stage4 |
7.530200E-01 |
| Stage3-vs-Stage4 |
7.684400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.166200E-01 |
| Normal-vs-AfricanAmerican |
2.943900E-02 |
| Normal-vs-Asian |
6.317800E-01 |
| Caucasian-vs-AfricanAmerican |
4.824100E-02 |
| Caucasian-vs-Asian |
2.778600E-01 |
| AfricanAmerican-vs-Asian |
9.081900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.002030E-01 |
| Normal-vs-Female |
5.307200E-01 |
| Male-vs-Female |
9.901700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.085400E-01 |
| Normal-vs-Extreme_Weight |
1.204030E-01 |
| Normal-vs-Obese |
1.278350E-01 |
| Normal-vs-Extreme_Obese |
4.139000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.895800E-01 |
| Normal_Weight-vs-Obese |
8.551200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.971200E-01 |
| Extreme_Weight-vs-Obese |
7.873600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.350400E-01 |
| Obese-vs-Extreme_Obese |
8.632200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.510620E-01 |
| Normal-vs-Age(41-60Yrs) |
6.075200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.963500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.322000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.225700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.575640E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.403400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.145600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.850100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.014200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.733600E-02 |
| Normal-VS-Type2 PRCC |
7.254600E-01 |
| Normal-VS-KIRP CIMP |
7.608600E-01 |
| Normal-VS-Unclassified PRCC |
9.489200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.530000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.575800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.063250E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.432600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.954400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.894800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.000800E-01 |
| Normal-vs-N1 |
5.868200E-01 |
| Normal-vs-N2 |
3.744200E-01 |
| N0-vs-N1 |
7.696400E-01 |
| N0-vs-N2 |
2.956800E-01 |
| N1-vs-N2 |
9.222400E-02 |
|
|
